What part of optometry do you enjoy the most?

Check out our latest poll!

This poll is for optometrists and eyecare professionals, only. It will close on Friday, April 8, 2022.

What part of optometry do you enjoy the most?

A. Clinical care
B. Patient interaction
C. Ability for good work-life balance
D. Intersection with industry
E. Professional collegiality
Related Videos
Related Content

Safety, efficacy of lotilaner ophthalmic solution for Demodex blepharitis treatment

March 31st 2023

Practical management EP 10: Getting started with marketing

March 30th 2023

Ophthalmology group to pay nearly $3 million to resolve optometrist referral kickback allegations

March 29th 2023

Practical management EP 9: Understanding the difference between branding & marketing

March 24th 2023

3-week therapeutics for MGD equivalent to 6-week treatment in efficacy and adverse events

March 27th 2023

OCT biomarkers associated with advanced age-related macular degeneration

March 27th 2023

Safety, efficacy of lotilaner ophthalmic solution for Demodex blepharitis treatment

March 31st 2023

Practical management EP 10: Getting started with marketing

March 30th 2023

Ophthalmology group to pay nearly $3 million to resolve optometrist referral kickback allegations

March 29th 2023

Practical management EP 9: Understanding the difference between branding & marketing

March 24th 2023

3-week therapeutics for MGD equivalent to 6-week treatment in efficacy and adverse events

March 27th 2023

OCT biomarkers associated with advanced age-related macular degeneration

March 27th 2023

Safety, efficacy of lotilaner ophthalmic solution for Demodex blepharitis treatment

March 31st 2023

Practical management EP 10: Getting started with marketing

March 30th 2023

Ophthalmology group to pay nearly $3 million to resolve optometrist referral kickback allegations

March 29th 2023

Practical management EP 9: Understanding the difference between branding & marketing

March 24th 2023

3-week therapeutics for MGD equivalent to 6-week treatment in efficacy and adverse events

March 27th 2023

OCT biomarkers associated with advanced age-related macular degeneration

March 27th 2023
© 2023 MJH Life Sciences

All rights reserved.